These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2862464)

  • 1. Two controlled trials of dry artificial surfactant: early effects and later outcome in babies with surfactant deficiency.
    Wilkinson A; Jenkins PA; Jeffrey JA
    Lancet; 1985 Aug; 2(8450):287-91. PubMed ID: 2862464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracheal aspirate surface tension in babies with hyaline membrane disease: effects of synthetic surfactant replacement.
    McMillan DD; Singhal N; Shukla AK; Schürch S
    Pediatr Pulmonol; 1998 Sep; 26(3):173-82. PubMed ID: 9773912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.
    Couser RJ; Ferrara TB; Ebert J; Hoekstra RE; Fangman JJ
    J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-specificity of surfactant deficiency in neonatal respiratory disorders.
    James DK; Chiswick ML; Harkes A; Williams M; Hallworth J
    Br Med J (Clin Res Ed); 1984 Jun; 288(6431):1635-8. PubMed ID: 6426671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bubble clicking in pharyngeal aspirate compared with lecithin/sphingomyelin ratio.
    Parkinson CE; Supramaniam G; Harvey D
    Biol Neonate; 1978; 34(5-6):269-74. PubMed ID: 581649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled trial of artificial surfactant to prevent respiratory distress syndrome.
    Halliday HL; McClure G; Reid MM; Lappin TR; Meban C; Thomas PS
    Lancet; 1984 Mar; 1(8375):476-8. PubMed ID: 6142208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary surfactant. I. In immature and mature babies.
    Hill CM; Brown BD; Morley CJ; Davis JA; Barson AJ
    Early Hum Dev; 1988 Mar; 16(2-3):143-51. PubMed ID: 3378520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow up of premature babies treated with artificial surfactant (ALEC).
    Morley CJ; Morley R
    Arch Dis Child; 1990 Jul; 65(7 Spec No):667-9. PubMed ID: 2201266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary surfactant and its clinical application.
    Jin HZ
    Chin Med J (Engl); 1991 Mar; 104(3):225-7. PubMed ID: 2065535
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD; Soll RF; Parad RB; Horbar JD; Feldman HA; Lucey JF; Taeusch HW
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation.
    Morley CJ; Greenough A; Miller NG; Bangham AD; Pool J; Wood S; South M; Davis JA; Vyas H
    Early Hum Dev; 1988 May; 17(1):41-54. PubMed ID: 3061771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: a controlled study].
    Sánchez-Mendiola M; Martínez-Natera OC; Herrera-Maldonado N; Ortega-Arroyo J
    Gac Med Mex; 2005; 141(4):267-71. PubMed ID: 16164120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease.
    Raju TN; Vidyasagar D; Bhat R; Sobel D; McCulloch KM; Anderson M; Maeta H; Levy PS; Furner S
    Lancet; 1987 Mar; 1(8534):651-6. PubMed ID: 2882083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial surfactant therapy for hyaline membrane disease.
    Wigglesworth JS
    Arch Dis Child; 1980 Oct; 55(10):753-4. PubMed ID: 6893647
    [No Abstract]   [Full Text] [Related]  

  • 15. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group.
    Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe hyaline membrane disease with surfactant (Curosurf). A collaborative clinical study.
    Büky B; Dévai G; Várady E; Rózsavölgyi A; Kovách I; Kovács A; Jancsó G; Waldinger K; Görgényi A; Zsolnai B
    Acta Paediatr Hung; 1990; 30(3-4):351-65. PubMed ID: 2083097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted early rescue surfactant in ventilated preterm infants using the click test.
    Osborn DA; Jeffery HE; Bredemeyer SL; Polverino JM; Reid S
    Pediatrics; 2000 Sep; 106(3):E30. PubMed ID: 10969114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.
    Harker LC; Merritt TA; Edwards DK
    J Perinatol; 1992 Jun; 12(2):129-33. PubMed ID: 1522430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.
    Shimada S; Raju TN; Bhat R; Maeta H; Vidyasagar D
    Pediatr Res; 1989 Dec; 26(6):565-9. PubMed ID: 2602035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.